CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Retrospective observational comparative study on drug utilization of proton pump inhibitors vs h2 receptor blockers

Author: 
Dr. Hari Krishna. Kommanaboina, Dr. Koya. Samyuktha, Shaik. Abdul Saleem Shaik. Munwar
Subject Area: 
Social Sciences and Humanities
Abstract: 

Aim of study: The objective of the study was to assess the retrospective observational comparative study on drug utilization of proton pump inhibitors Vs H2 receptor blockers. Methodology: 150 patients are included in this study. All the patients were undergoing Proton Pump Inhibitors and H-2 receptor blockers therapy and/or co – morbidities were included in the study. The study was conducted in the General Medicine Unit (IPD), Intensive Care Unit, Surgery, Orthopedic and all other departments in a multispecialty tertiary care hospital. The patient’s demographic status like name, age, gender, occupation, address, IP number and date of admission of patients. Etc., were collected. The patient’s lifestyle profile was collected by individual patients by direct interaction with the patients or with their care takers for any lifestyle modifications. The patient’s Proton Pump Inhibitors and H-2 receptor blockers medication prescribed by the physician, along with the dosage was recorded. The appropriateness of Proton Pump Inhibitors and H-2 receptor blockers drugs like Dose, Dosage form, Duration of treatment, Route and frequency of administration with standard guidelines was also recorded. Results: Results of patient population included in the study are out of 150 males 98(65%) and females 52 (35%) are using Anti-Ulcer drugs. Based on hospitalization condition in total study population for fever and pain condition Pantoprazole (9%) given in 14 prescriptions and Ranitidine (11%) given in 16 prescriptions. In total study population based on dose and dose frequency Pantoprazole (PPI) 40mg O.D is prescribed in 17% of prescriptions and Ranitidine (H2RA) 150mg B.D is prescribed in 14% prescriptions. Based on use of Anti-Ulcer drugs in NSAID prophylaxis in total study population Pantoprazole (PPI) is prescribed in 17% prescriptions and Ranitidine (H2RA) is prescribed in 13% prescriptions.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran